1. Anticoagulant Therapy in Atrial Fibrillation for Stroke Prevention: Assessment of Agreement Between Clinicians’ Decision and CHA2DS2-VASc and HAS-BLED Scores.
- Author
-
Balaghi-Inalou, Marzieh, Parsa, Saeed Alipour, Gachkar, Latif, and Andalib, Sasan
- Subjects
- *
ANTICOAGULANTS , *ATRIAL fibrillation diagnosis , *STROKE prevention , *ATRIAL fibrillation , *ELECTROCARDIOGRAPHY , *MEDICAL prescriptions , *RISK assessment , *STATISTICS , *DECISION making in clinical medicine - Abstract
Introduction: To prevent stroke, anticoagulants should be administered after calculation of CHA2DS2-VASc and HAS-BLED scores in patients with Atrial Fibrillation (AF); nonetheless, these scores are sometimes neglected in clinical settings.Aim: The present study was designed to assess agreement of anticoagulant therapy according to clinicians and CHA2DS2-VASc and HAS-BLED scores in Iranian AF patients in Moddares Hospital.Methods: AF patients were diagnosed according to clinical history, clinical examination, and electrocardiogram. Data including the anticoagulant prescription according to clinicians were recorded. CHA2DS2-VASc and HAS-BLED scores were then calculated for each patient. Agreement of anticoagulant therapy according to clinicians and CHA2DS2-VASc and HAS-BLED scores was analyzed using Cohen’s kappa coefficient.Results: 97.5% of the patients (n = 117) were appropriately (according CHA2DS2-VASc and HAS-BLED scores) treated with anticoagulants by clinicians, notwithstanding a 2.5% of patients with inappropriate anticoagulant therapy (n = 3). The Cohen’s kappa coefficient was 0.81 (P = 0.0).Conclusions: The findings of the present study suggest an almost perfect agreement between anticoagulant therapy according to clinicians and that according to CHA2DS2-VASc and HAS-BLED scores in the studied population. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF